Early Growth Response 1 (Egr1) Is a Transcriptional Activator of NOX4 in Oxidative Stress of Diabetic Kidney Disease

Figure 4

Egr1, NOX4, and α-SMA expression in HFD/STZ-induced diabetic mice transfected with pGPU6-shEgr1 plasmid. Diabetic mice were treated with either pGPU6-shEgr1 silencing plasmid or with a pGPU6 vector once a week for four weeks via rapid injection of a large volume of DNA solution through the tail vein. (a) Levels of Egr1, NOX4, and α-SMA mRNA were measured using RT-qPCR. (b and c) Levels of Egr1, NOX4, and α-SMA protein were measured using Western blotting assays. (d) NOX4 concentration, (e) ROS concentration, and (f) α-SMA concentration were measured using ELISAs. The results are expressed as foldchange over baseline (pGPU6 vector group). Values are mean ± SD. and versus the pGPU6 vector group. (g) Masson staining and immunohistochemical staining of Egr1, NOX4, and α-SMA.

(a)

(b)

(c)

(d)

(e)

(f)

(g)